Global 1-Indanone Market Growth 2026-2032

July 2026 | 79 pages | ID: G6C57C114231EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global 1-Indanone market size is predicted to grow from US$ 48.16 million in 2025 to US$ 66.23 million in 2032; it is expected to grow at a CAGR of 4.6% from 2026 to 2032.

1-Indanone (CAS 83-33-0) is a white to pale yellow crystalline powder that serves as a key intermediate in pharmaceutical synthesis, particularly as an essential raw material for the anti-HIV drug indinavir and the Parkinson's disease drug rasagiline. Its upstream raw materials mainly consist of the petrochemical derivatives indan and benzene-based compounds. Downstream customers primarily include active pharmaceutical ingredient manufacturers and pharmaceutical companies. In 2025, the global production capacity of 1-indanone is estimated at approximately 5,210 metric tons, with sales volume of around 4,689 metric tons and an average ex-factory price of approximately US$ 10,500 per metric ton. The industry's gross profit margin typically ranges from 16% to 24%, with notable variations among producers of different purity grades and production scales.

Major producers in the global 1-indanone market include JFE Chemical in Japan and several pharmaceutical intermediate companies in China, which together form the supply system for industrial-grade products. Leveraging its petrochemical industry chain and cost characteristics, China holds a certain share in global 1-indanone production. Stable growth in market demand is primarily driven by the sustained production of antiretroviral drugs such as indinavir and the rising demand for Parkinson's disease drugs like rasagiline in aging societies. Meanwhile, the gradual expansion of its applications in fine chemical sectors such as fragrances, dyes, and optoelectronic materials provides diversified support to the industry.

Future technological upgrades will center on green synthesis processes and continuous flow production to address the high chromium pollution and energy intensity of traditional oxidation routes. Research into biocatalytic methods and novel catalytic oxidation systems is advancing, which is expected to enhance production compliance and cost competitiveness under tightening environmental regulations. The post-patent generic drug volume growth will boost demand for high-quality 1-indanone, prompting producers to upgrade product structures toward pharmaceutical grade and higher purity. Furthermore, active exploration of indanone-derived new molecules in antiviral and anti-inflammatory drug research and development will render custom synthesis and contract development and manufacturing services emerging growth highlights for the industry.

Core growth drivers stem from the rigid demand of global chronic disease management. The long-term widespread use of HIV treatments and the increasing number of Parkinson's disease patients due to population aging constitute irreplaceable raw material requirements for 1-indanone. The expansion of generic drug markets leads to continued growth in active pharmaceutical ingredient intermediate procurement, especially as local formulation production capacity in emerging markets further boosts upstream intermediate trade. Moreover, supply chain interactions between China and India in the pharmaceutical intermediate sector help rationalize production costs and improve supply reliability, thereby enhancing overall market accessibility.

The industry still faces notable obstacles. Stricter environmental regulations impose high treatment costs for chromium-containing wastewater from traditional processes, forcing some small-scale producers to face remediation pressure or choose to exit. Price volatility of raw materials indan and benzene-based compounds, largely influenced by international crude oil markets and the downstream aromatics industry chain, brings uncertainty to cost control for producers. Additionally, product applications remain relatively narrow, with excessive reliance on a few mature drugs. If these drugs are replaced by next-generation therapies or see drastic price declines after patent expiration, market demand may experience periodic contraction, highlighting the industry's need for strengthened resilience.

LP Information, Inc. (LPI) ' newest research report, the ?1-Indanone Industry Forecast? looks at past sales and reviews total world 1-Indanone sales in 2025, providing a comprehensive analysis by region and market sector of projected 1-Indanone sales for 2026 through 2032. With 1-Indanone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 1-Indanone industry.

This Insight Report provides a comprehensive analysis of the global 1-Indanone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 1-Indanone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global 1-Indanone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 1-Indanone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 1-Indanone.

This report presents a comprehensive overview, market shares, and growth opportunities of 1-Indanone market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Purity 98%
  • Purity 99%
  • Others
Segmentation by Grade:
  • Industrial Grade
  • Pharmaceutical Grade
  • Other
Segmentation by Sales Channel:
  • Online Sales
  • Offline Sales
Segmentation by Application:
  • Indinavir Intermediates
  • Rasagiline Intermediates
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • JFE Chemical
  • V & V Pharma Industries
  • Siping Fine Chemical
  • Hefei TianRui Pharmaceutical Chemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global 1-Indanone market?
What factors are driving 1-Indanone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 1-Indanone market opportunities vary by end market size?
How does 1-Indanone break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global 1-Indanone Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for 1-Indanone by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for 1-Indanone by Country/Region, 2021, 2025 & 2032
2.2 1-Indanone Segment by Type
  2.2.1 Purity 98%
  2.2.2 Purity 99%
  2.2.3 Others
  2.2.4 1-Indanone Sales by Type
    2.2.4.1 Global 1-Indanone Sales Market Share by Type (2021-2026)
    2.2.4.2 Global 1-Indanone Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global 1-Indanone Sale Price by Type (2021-2026)
2.3 1-Indanone Segment by Grade
  2.3.1 Industrial Grade
  2.3.2 Pharmaceutical Grade
  2.3.3 Other
  2.3.4 1-Indanone Sales by Grade
    2.3.4.1 Global 1-Indanone Sales Market Share by Grade (2021-2026)
    2.3.4.2 Global 1-Indanone Revenue and Market Share by Grade (2021-2026)
    2.3.4.3 Global 1-Indanone Sale Price by Grade (2021-2026)
2.4 1-Indanone Segment by Sales Channel
  2.4.1 Online Sales
  2.4.2 Offline Sales
  2.4.3 1-Indanone Sales by Sales Channel
    2.4.3.1 Global 1-Indanone Sales Market Share by Sales Channel (2021-2026)
    2.4.3.2 Global 1-Indanone Revenue and Market Share by Sales Channel (2021-2026)
    2.4.3.3 Global 1-Indanone Sale Price by Sales Channel (2021-2026)
2.5 1-Indanone Segment by Application
  2.5.1 Indinavir Intermediates
  2.5.2 Rasagiline Intermediates
  2.5.3 Other
  2.5.4 1-Indanone Sales by Application
    2.5.4.1 Global 1-Indanone Sale Market Share by Application (2021-2026)
    2.5.4.2 Global 1-Indanone Revenue and Market Share by Application (2021-2026)
    2.5.4.3 Global 1-Indanone Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global 1-Indanone Breakdown Data by Company
  3.1.1 Global 1-Indanone Annual Sales by Company (2021-2026)
  3.1.2 Global 1-Indanone Sales Market Share by Company (2021-2026)
3.2 Global 1-Indanone Annual Revenue by Company (2021-2026)
  3.2.1 Global 1-Indanone Revenue by Company (2021-2026)
  3.2.2 Global 1-Indanone Revenue Market Share by Company (2021-2026)
3.3 Global 1-Indanone Sale Price by Company
3.4 Key Manufacturers 1-Indanone Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers 1-Indanone Product Location Distribution
  3.4.2 Players 1-Indanone Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR 1-INDANONE BY GEOGRAPHIC REGION

4.1 World Historic 1-Indanone Market Size by Geographic Region (2021-2026)
  4.1.1 Global 1-Indanone Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global 1-Indanone Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic 1-Indanone Market Size by Country/Region (2021-2026)
  4.2.1 Global 1-Indanone Annual Sales by Country/Region (2021-2026)
  4.2.2 Global 1-Indanone Annual Revenue by Country/Region (2021-2026)
4.3 Americas 1-Indanone Sales Growth
4.4 APAC 1-Indanone Sales Growth
4.5 Europe 1-Indanone Sales Growth
4.6 Middle East & Africa 1-Indanone Sales Growth

5 AMERICAS

5.1 Americas 1-Indanone Sales by Country
  5.1.1 Americas 1-Indanone Sales by Country (2021-2026)
  5.1.2 Americas 1-Indanone Revenue by Country (2021-2026)
5.2 Americas 1-Indanone Sales by Type (2021-2026)
5.3 Americas 1-Indanone Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC 1-Indanone Sales by Region
  6.1.1 APAC 1-Indanone Sales by Region (2021-2026)
  6.1.2 APAC 1-Indanone Revenue by Region (2021-2026)
6.2 APAC 1-Indanone Sales by Type (2021-2026)
6.3 APAC 1-Indanone Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe 1-Indanone by Country
  7.1.1 Europe 1-Indanone Sales by Country (2021-2026)
  7.1.2 Europe 1-Indanone Revenue by Country (2021-2026)
7.2 Europe 1-Indanone Sales by Type (2021-2026)
7.3 Europe 1-Indanone Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa 1-Indanone by Country
  8.1.1 Middle East & Africa 1-Indanone Sales by Country (2021-2026)
  8.1.2 Middle East & Africa 1-Indanone Revenue by Country (2021-2026)
8.2 Middle East & Africa 1-Indanone Sales by Type (2021-2026)
8.3 Middle East & Africa 1-Indanone Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 1-Indanone
10.3 Manufacturing Process Analysis of 1-Indanone
10.4 Industry Chain Structure of 1-Indanone

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 1-Indanone Distributors
11.3 1-Indanone Customer

12 WORLD FORECAST REVIEW FOR 1-INDANONE BY GEOGRAPHIC REGION

12.1 Global 1-Indanone Market Size Forecast by Region
  12.1.1 Global 1-Indanone Forecast by Region (2027-2032)
  12.1.2 Global 1-Indanone Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global 1-Indanone Forecast by Type (2027-2032)
12.7 Global 1-Indanone Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 JFE Chemical
  13.1.1 JFE Chemical Company Information
  13.1.2 JFE Chemical 1-Indanone Product Portfolios and Specifications
  13.1.3 JFE Chemical 1-Indanone Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 JFE Chemical Main Business Overview
  13.1.5 JFE Chemical Latest Developments
13.2 V & V Pharma Industries
  13.2.1 V & V Pharma Industries Company Information
  13.2.2 V & V Pharma Industries 1-Indanone Product Portfolios and Specifications
  13.2.3 V & V Pharma Industries 1-Indanone Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 V & V Pharma Industries Main Business Overview
  13.2.5 V & V Pharma Industries Latest Developments
13.3 Siping Fine Chemical
  13.3.1 Siping Fine Chemical Company Information
  13.3.2 Siping Fine Chemical 1-Indanone Product Portfolios and Specifications
  13.3.3 Siping Fine Chemical 1-Indanone Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Siping Fine Chemical Main Business Overview
  13.3.5 Siping Fine Chemical Latest Developments
13.4 Hefei TianRui Pharmaceutical Chemical
  13.4.1 Hefei TianRui Pharmaceutical Chemical Company Information
  13.4.2 Hefei TianRui Pharmaceutical Chemical 1-Indanone Product Portfolios and Specifications
  13.4.3 Hefei TianRui Pharmaceutical Chemical 1-Indanone Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Hefei TianRui Pharmaceutical Chemical Main Business Overview
  13.4.5 Hefei TianRui Pharmaceutical Chemical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. 1-Indanone Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. 1-Indanone Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Purity 98%
Table 4. Major Players of Purity 99%
Table 5. Major Players of Others
Table 6. Global 1-Indanone Sales by Type (2021-2026) & (Tons)
Table 7. Global 1-Indanone Sales Market Share by Type (2021-2026)
Table 8. Global 1-Indanone Revenue by Type (2021-2026) & ($ million)
Table 9. Global 1-Indanone Revenue Market Share by Type (2021-2026)
Table 10. Global 1-Indanone Sale Price by Type (2021-2026) & (US$/kg)
Table 11. Major Players of Industrial Grade
Table 12. Major Players of Pharmaceutical Grade
Table 13. Major Players of Other
Table 14. Global 1-Indanone Sales by Grade (2021-2026) & (Tons)
Table 15. Global 1-Indanone Sales Market Share by Grade (2021-2026)
Table 16. Global 1-Indanone Revenue by Grade (2021-2026) & ($ million)
Table 17. Global 1-Indanone Revenue Market Share by Grade (2021-2026)
Table 18. Global 1-Indanone Sale Price by Grade (2021-2026) & (US$/kg)
Table 19. Major Players of Online Sales
Table 20. Major Players of Offline Sales
Table 21. Global 1-Indanone Sales by Sales Channel (2021-2026) & (Tons)
Table 22. Global 1-Indanone Sales Market Share by Sales Channel (2021-2026)
Table 23. Global 1-Indanone Revenue by Sales Channel (2021-2026) & ($ million)
Table 24. Global 1-Indanone Revenue Market Share by Sales Channel (2021-2026)
Table 25. Global 1-Indanone Sale Price by Sales Channel (2021-2026) & (US$/kg)
Table 26. Global 1-Indanone Sale by Application (2021-2026) & (Tons)
Table 27. Global 1-Indanone Sale Market Share by Application (2021-2026)
Table 28. Global 1-Indanone Revenue by Application (2021-2026) & ($ million)
Table 29. Global 1-Indanone Revenue Market Share by Application (2021-2026)
Table 30. Global 1-Indanone Sale Price by Application (2021-2026) & (US$/kg)
Table 31. Global 1-Indanone Sales by Company (2021-2026) & (Tons)
Table 32. Global 1-Indanone Sales Market Share by Company (2021-2026)
Table 33. Global 1-Indanone Revenue by Company (2021-2026) & ($ millions)
Table 34. Global 1-Indanone Revenue Market Share by Company (2021-2026)
Table 35. Global 1-Indanone Sale Price by Company (2021-2026) & (US$/kg)
Table 36. Key Manufacturers 1-Indanone Producing Area Distribution and Sales Area
Table 37. Players 1-Indanone Products Offered
Table 38. 1-Indanone Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global 1-Indanone Sales by Geographic Region (2021-2026) & (Tons)
Table 42. Global 1-Indanone Sales Market Share Geographic Region (2021-2026)
Table 43. Global 1-Indanone Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global 1-Indanone Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global 1-Indanone Sales by Country/Region (2021-2026) & (Tons)
Table 46. Global 1-Indanone Sales Market Share by Country/Region (2021-2026)
Table 47. Global 1-Indanone Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global 1-Indanone Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas 1-Indanone Sales by Country (2021-2026) & (Tons)
Table 50. Americas 1-Indanone Sales Market Share by Country (2021-2026)
Table 51. Americas 1-Indanone Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas 1-Indanone Sales by Type (2021-2026) & (Tons)
Table 53. Americas 1-Indanone Sales by Application (2021-2026) & (Tons)
Table 54. APAC 1-Indanone Sales by Region (2021-2026) & (Tons)
Table 55. APAC 1-Indanone Sales Market Share by Region (2021-2026)
Table 56. APAC 1-Indanone Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC 1-Indanone Sales by Type (2021-2026) & (Tons)
Table 58. APAC 1-Indanone Sales by Application (2021-2026) & (Tons)
Table 59. Europe 1-Indanone Sales by Country (2021-2026) & (Tons)
Table 60. Europe 1-Indanone Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe 1-Indanone Sales by Type (2021-2026) & (Tons)
Table 62. Europe 1-Indanone Sales by Application (2021-2026) & (Tons)
Table 63. Middle East & Africa 1-Indanone Sales by Country (2021-2026) & (Tons)
Table 64. Middle East & Africa 1-Indanone Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa 1-Indanone Sales by Type (2021-2026) & (Tons)
Table 66. Middle East & Africa 1-Indanone Sales by Application (2021-2026) & (Tons)
Table 67. Key Market Drivers & Growth Opportunities of 1-Indanone
Table 68. Key Market Challenges & Risks of 1-Indanone
Table 69. Key Industry Trends of 1-Indanone
Table 70. 1-Indanone Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. 1-Indanone Distributors List
Table 73. 1-Indanone Customer List
Table 74. Global 1-Indanone Sales Forecast by Region (2027-2032) & (Tons)
Table 75. Global 1-Indanone Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas 1-Indanone Sales Forecast by Country (2027-2032) & (Tons)
Table 77. Americas 1-Indanone Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC 1-Indanone Sales Forecast by Region (2027-2032) & (Tons)
Table 79. APAC 1-Indanone Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe 1-Indanone Sales Forecast by Country (2027-2032) & (Tons)
Table 81. Europe 1-Indanone Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa 1-Indanone Sales Forecast by Country (2027-2032) & (Tons)
Table 83. Middle East & Africa 1-Indanone Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global 1-Indanone Sales Forecast by Type (2027-2032) & (Tons)
Table 85. Global 1-Indanone Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global 1-Indanone Sales Forecast by Application (2027-2032) & (Tons)
Table 87. Global 1-Indanone Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. JFE Chemical Basic Information, 1-Indanone Manufacturing Base, Sales Area and Its Competitors
Table 89. JFE Chemical 1-Indanone Product Portfolios and Specifications
Table 90. JFE Chemical 1-Indanone Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 91. JFE Chemical Main Business
Table 92. JFE Chemical Latest Developments
Table 93. V & V Pharma Industries Basic Information, 1-Indanone Manufacturing Base, Sales Area and Its Competitors
Table 94. V & V Pharma Industries 1-Indanone Product Portfolios and Specifications
Table 95. V & V Pharma Industries 1-Indanone Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 96. V & V Pharma Industries Main Business
Table 97. V & V Pharma Industries Latest Developments
Table 98. Siping Fine Chemical Basic Information, 1-Indanone Manufacturing Base, Sales Area and Its Competitors
Table 99. Siping Fine Chemical 1-Indanone Product Portfolios and Specifications
Table 100. Siping Fine Chemical 1-Indanone Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 101. Siping Fine Chemical Main Business
Table 102. Siping Fine Chemical Latest Developments
Table 103. Hefei TianRui Pharmaceutical Chemical Basic Information, 1-Indanone Manufacturing Base, Sales Area and Its Competitors
Table 104. Hefei TianRui Pharmaceutical Chemical 1-Indanone Product Portfolios and Specifications
Table 105. Hefei TianRui Pharmaceutical Chemical 1-Indanone Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. Hefei TianRui Pharmaceutical Chemical Main Business
Table 107. Hefei TianRui Pharmaceutical Chemical Latest Developments

LIST OF FIGURES

Figure 1. Picture of 1-Indanone
Figure 2. 1-Indanone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 1-Indanone Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global 1-Indanone Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. 1-Indanone Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. 1-Indanone Sales Market Share by Country/Region (2025)
Figure 10. 1-Indanone Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Purity 98%
Figure 12. Product Picture of Purity 99%
Figure 13. Product Picture of Others
Figure 14. Global 1-Indanone Sales Market Share by Type in 2026
Figure 15. Global 1-Indanone Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Industrial Grade
Figure 17. Product Picture of Pharmaceutical Grade
Figure 18. Product Picture of Other
Figure 19. Global 1-Indanone Sales Market Share by Grade in 2026
Figure 20. Global 1-Indanone Revenue Market Share by Grade (2021-2026)
Figure 21. Product Picture of Online Sales
Figure 22. Product Picture of Offline Sales
Figure 23. Global 1-Indanone Sales Market Share by Sales Channel in 2026
Figure 24. Global 1-Indanone Revenue Market Share by Sales Channel (2021-2026)
Figure 25. 1-Indanone Consumed in Indinavir Intermediates
Figure 26. Global 1-Indanone Market: Indinavir Intermediates (2021-2026) & (Tons)
Figure 27. 1-Indanone Consumed in Rasagiline Intermediates
Figure 28. Global 1-Indanone Market: Rasagiline Intermediates (2021-2026) & (Tons)
Figure 29. 1-Indanone Consumed in Other
Figure 30. Global 1-Indanone Market: Other (2021-2026) & (Tons)
Figure 31. Global 1-Indanone Sale Market Share by Application (2025)
Figure 32. Global 1-Indanone Revenue Market Share by Application in 2025
Figure 33. 1-Indanone Sales by Company in 2025 (Tons)
Figure 34. Global 1-Indanone Sales Market Share by Company in 2025
Figure 35. 1-Indanone Revenue by Company in 2025 ($ millions)
Figure 36. Global 1-Indanone Revenue Market Share by Company in 2025
Figure 37. Global 1-Indanone Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global 1-Indanone Revenue Market Share by Geographic Region in 2025
Figure 39. Americas 1-Indanone Sales 2021-2026 (Tons)
Figure 40. Americas 1-Indanone Revenue 2021-2026 ($ millions)
Figure 41. APAC 1-Indanone Sales 2021-2026 (Tons)
Figure 42. APAC 1-Indanone Revenue 2021-2026 ($ millions)
Figure 43. Europe 1-Indanone Sales 2021-2026 (Tons)
Figure 44. Europe 1-Indanone Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa 1-Indanone Sales 2021-2026 (Tons)
Figure 46. Middle East & Africa 1-Indanone Revenue 2021-2026 ($ millions)
Figure 47. Americas 1-Indanone Sales Market Share by Country in 2025
Figure 48. Americas 1-Indanone Revenue Market Share by Country (2021-2026)
Figure 49. Americas 1-Indanone Sales Market Share by Type (2021-2026)
Figure 50. Americas 1-Indanone Sales Market Share by Application (2021-2026)
Figure 51. United States 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC 1-Indanone Sales Market Share by Region in 2025
Figure 56. APAC 1-Indanone Revenue Market Share by Region (2021-2026)
Figure 57. APAC 1-Indanone Sales Market Share by Type (2021-2026)
Figure 58. APAC 1-Indanone Sales Market Share by Application (2021-2026)
Figure 59. China 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 63. India 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe 1-Indanone Sales Market Share by Country in 2025
Figure 67. Europe 1-Indanone Revenue Market Share by Country (2021-2026)
Figure 68. Europe 1-Indanone Sales Market Share by Type (2021-2026)
Figure 69. Europe 1-Indanone Sales Market Share by Application (2021-2026)
Figure 70. Germany 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 71. France 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 72. UK 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa 1-Indanone Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa 1-Indanone Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa 1-Indanone Sales Market Share by Application (2021-2026)
Figure 78. Egypt 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries 1-Indanone Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of 1-Indanone in 2026
Figure 84. Manufacturing Process Analysis of 1-Indanone
Figure 85. Industry Chain Structure of 1-Indanone
Figure 86. Channels of Distribution
Figure 87. Global 1-Indanone Sales Market Forecast by Region (2027-2032)
Figure 88. Global 1-Indanone Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global 1-Indanone Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global 1-Indanone Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global 1-Indanone Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global 1-Indanone Revenue Market Share Forecast by Application (2027-2032)


More Publications